Abstract
BackgroundXEN glaucoma implant (XEN gel stent, Aquesys, Inc) is a new minimally invasive device approved for the treatment of glaucoma.Case presentationA 45 year old female was being followed and treated for primary open angle glaucoma in our tertiary referral center. Due to failure of medical treatment in controlling the glaucoma, surgery was offered to the patient. The XEN 45 μ-fistula implant was successfully placed in both eyes and adequate intraocular pressure control was achieved for 4 months. The left eye pressure then increased and the XEN implant was found in the anterior chamber. Topical intraocular pressure lowering therapy had to be re-initiated to achieve adequate pressure control.ConclusionWe describe a new potential complication of the XEN glaucoma implant.
Highlights
XEN glaucoma implant (XEN gel stent, Aquesys, Inc) is a new minimally invasive device approved for the treatment of glaucoma
Case presentation In our report we present a case of dislocation of the XEN implant into the anterior chamber
XEN implant has gained its position in our unit in the management of open angle glaucoma and we have performed over 40 cases during the first year
Summary
XEN glaucoma implant (XEN gel stent, Aquesys, Inc) is a new minimally invasive device approved for the treatment of glaucoma. The XEN implant is one of the new commercially available MIGS devices that can be offered to glaucoma patients. Reports about XEN implantation of different lumen tubes suggest favorable outcomes regarding the intraocular pressure control and number of pressure lowering medications [5, 6]. Case presentation In our report we present a case of dislocation of the XEN implant into the anterior chamber.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.